SAN FRANCISCO (AFX) -- The jury in the most recent liability trial over Merck Co.'s Vioxx treatment has reached a verdict, the Wall Street Journal report late Wednesday on its Web site. This story was supplied by MarketWatch. For further information see www.marketwatch.com.